Patent 11518738 was granted and assigned to Signum Biosciences on December, 2022 by the United States Patent and Trademark Office.
The present invention provides compounds useful in treating or preventing inflammation, acne, bacterial conditions and promoting the appearance of healthy skin and compositions including these compounds.